<DOC>
	<DOCNO>NCT00151749</DOCNO>
	<brief_summary>The purpose study see safe effective tolerable use WelChol® type 2 diabetes added insulin alone combination anti-diabetic drug</brief_summary>
	<brief_title>WelChol® Insulin Treating Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>Ages 18 75 year , inclusive Diagnosed type 2 diabetes Stable insulin therapy 6 week Stable dose antidiabetic medication 90 day Hemoglobin A1c value 7.5 % 9.5 % C peptide great 0.5 ng/mL Prescribed ADA diet History type 1 diabetes ketoacidosis History pancreatitis Uncontrolled hypertension Allergy toxic response colesevelam component Serum LDLC le 60 mg/dL Serum TG great 500 mg/dL Body mass index ( BMI ) great 45 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Diabetes mellitus</keyword>
</DOC>